 Conference Call Scheduled for Tuesday, November 16th at 11:30 AM EST NORTHVALE, NJ ACCESSWIRE November 15, 2021 Elite Pharmaceuticals, Inc. Elite or the CompanyOTCQB:ELTP, a specialty pharmaceutical company developing niche generic products, announced results for the second quarter of fiscal year 2022 ended September 30, 2021 Second Quarter. Consolidated revenues for the Second Quarter were 8.6 million, an increase of 1.2 million or 16 as compared to the corresponding period of the prior year, primarily due to stronger sales of Amphetamine IR Tablets and Amphetamine ER Capsules. 